. Author manuscript; available in PMC: 2015 Feb 1.

Published in final edited form as: Reproduction. 2014 May 6;148(1):109–117. doi: 10.1530/REP-13-0303

Table 2. Summary of results obtained from VEGF-165 treatment.

Group (cell #)	# of developed/ recovered grafts (%)	# of blood vessels/graft (x̄±SEM)	# of tubules/graft (x̄±SEM)	# of tubules with spermatogenesis/graft^* (x̄±SEM)
10×10⁶	32/35(92)	49.8±6.2^a	100.8±23^a	11.3±3.3^a
10×10⁶ VEGF-165	9/12(75)	50.0±3.7^a	78.2±9.7^a	18.6±2.2^b

: values with different superscripts within columns are significantly different (p<0.05)

Presence of UCHL1⁺ spermatogonia at 12 weeks